By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer

Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2015-06, Vol.6 (18), p.16461-16470
Hauptverfasser: Zhang, Qing, Song, Yanyan, Chen, Wei, Wang, Xiaohui, Miao, Zhifeng, Cao, Liu, Li, Feng, Wang, Guiling
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16470
container_issue 18
container_start_page 16461
container_title Oncotarget
container_volume 6
creator Zhang, Qing
Song, Yanyan
Chen, Wei
Wang, Xiaohui
Miao, Zhifeng
Cao, Liu
Li, Feng
Wang, Guiling
description Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.
doi_str_mv 10.18632/oncotarget.3889
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMottTuXeYHWJvnJNkIdapWqBREcRkymTtjpJ0ZkqnQf2-14uNuzoXD-RYfQueUXFKdcTZtG9_2LtbQX3KtzREaUiPMhEnJj__8AzRO6Y3sTwqlmTlFA5YRo5USQzS_3uEIPm5DH5oaL-aznF7gh9VjznDadl2ElCDhjtEXV9FpHjqKQ4Nrl_oYPPau8RDP0Enl1gnG3zlCz7c3T_lislzd3eez5cQLkvUTrg0FL7wGzY3LZFn50pWuUIpoITJhqIJCsUKCLERFCiaVkY5qoKrkUpd8hK4O3G5bbKD00PTRrW0Xw8bFnW1dsP-bJrzaun23QhrDNNsDyAHgY5tShOpnS4n9kmp_pdpPqfwDY0prGg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Zhang, Qing ; Song, Yanyan ; Chen, Wei ; Wang, Xiaohui ; Miao, Zhifeng ; Cao, Liu ; Li, Feng ; Wang, Guiling</creator><creatorcontrib>Zhang, Qing ; Song, Yanyan ; Chen, Wei ; Wang, Xiaohui ; Miao, Zhifeng ; Cao, Liu ; Li, Feng ; Wang, Guiling</creatorcontrib><description>Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.3889</identifier><identifier>PMID: 26098774</identifier><language>eng</language><publisher>Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>Oncotarget, 2015-06, Vol.6 (18), p.16461-16470</ispartof><rights>Copyright: © 2015 Zhang et al. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</citedby><cites>FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599282/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599282/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Zhang, Qing</creatorcontrib><creatorcontrib>Song, Yanyan</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Wang, Xiaohui</creatorcontrib><creatorcontrib>Miao, Zhifeng</creatorcontrib><creatorcontrib>Cao, Liu</creatorcontrib><creatorcontrib>Li, Feng</creatorcontrib><creatorcontrib>Wang, Guiling</creatorcontrib><title>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</title><title>Oncotarget</title><description>Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEUhYMottTuXeYHWJvnJNkIdapWqBREcRkymTtjpJ0ZkqnQf2-14uNuzoXD-RYfQueUXFKdcTZtG9_2LtbQX3KtzREaUiPMhEnJj__8AzRO6Y3sTwqlmTlFA5YRo5USQzS_3uEIPm5DH5oaL-aznF7gh9VjznDadl2ElCDhjtEXV9FpHjqKQ4Nrl_oYPPau8RDP0Enl1gnG3zlCz7c3T_lislzd3eez5cQLkvUTrg0FL7wGzY3LZFn50pWuUIpoITJhqIJCsUKCLERFCiaVkY5qoKrkUpd8hK4O3G5bbKD00PTRrW0Xw8bFnW1dsP-bJrzaun23QhrDNNsDyAHgY5tShOpnS4n9kmp_pdpPqfwDY0prGg</recordid><startdate>20150630</startdate><enddate>20150630</enddate><creator>Zhang, Qing</creator><creator>Song, Yanyan</creator><creator>Chen, Wei</creator><creator>Wang, Xiaohui</creator><creator>Miao, Zhifeng</creator><creator>Cao, Liu</creator><creator>Li, Feng</creator><creator>Wang, Guiling</creator><general>Impact Journals LLC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20150630</creationdate><title>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</title><author>Zhang, Qing ; Song, Yanyan ; Chen, Wei ; Wang, Xiaohui ; Miao, Zhifeng ; Cao, Liu ; Li, Feng ; Wang, Guiling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-3891ec4c8e839a65dfcdadab77084464917eb72b5e5b4f0b25795a18e17d358d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Qing</creatorcontrib><creatorcontrib>Song, Yanyan</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Wang, Xiaohui</creatorcontrib><creatorcontrib>Miao, Zhifeng</creatorcontrib><creatorcontrib>Cao, Liu</creatorcontrib><creatorcontrib>Li, Feng</creatorcontrib><creatorcontrib>Wang, Guiling</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Qing</au><au>Song, Yanyan</au><au>Chen, Wei</au><au>Wang, Xiaohui</au><au>Miao, Zhifeng</au><au>Cao, Liu</au><au>Li, Feng</au><au>Wang, Guiling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer</atitle><jtitle>Oncotarget</jtitle><date>2015-06-30</date><risdate>2015</risdate><volume>6</volume><issue>18</issue><spage>16461</spage><epage>16470</epage><pages>16461-16470</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Microrchidia (MORC) family CW-type zinc-finger 2 (MORC2) regulates chromatin remodeling during the DNA-damage response, represses gene transcription, promotes lipogenesis. Here, we found that MORC2 down-regulated p21 by recruiting HDAC1 to the p21 promoter, in a p53-independent manner. MORC2-mediated down-regulation of p21 in turn promoted cell cycle progression in gastric cancer cells. Furthermore, MORC2 expression correlated negatively with p21 expression in gastric tumors in patients. We suggest that MORC2 may be a potential therapeutic target in cancer.</abstract><pub>Impact Journals LLC</pub><pmid>26098774</pmid><doi>10.18632/oncotarget.3889</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2015-06, Vol.6 (18), p.16461-16470
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals
subjects Research Paper
title By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T22%3A16%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=By%20recruiting%20HDAC1,%20MORC2%20suppresses%20p21Waf1/Cip1%20in%20gastric%20cancer&rft.jtitle=Oncotarget&rft.au=Zhang,%20Qing&rft.date=2015-06-30&rft.volume=6&rft.issue=18&rft.spage=16461&rft.epage=16470&rft.pages=16461-16470&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.3889&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4599282%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26098774&rfr_iscdi=true